Tissue Distribution and Antifungal Effect of Liposomal Itraconazole in Experimental Cryptococcosis and

[1]  Claude Carbón,et al.  Reduction of free amphotericin B acute toxicity in mice after intravenous administration of empty liposomes. , 1990, The Journal of infectious diseases.

[2]  R. Hector,et al.  Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis , 1990, Antimicrobial Agents and Chemotherapy.

[3]  J. Bartlett,et al.  Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. , 1991, Reviews of infectious diseases.

[4]  Claude Carbón,et al.  Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits. , 1989, The Journal of pharmacology and experimental therapeutics.

[5]  Aquilur Rahman,et al.  Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice , 1989, Antimicrobial Agents and Chemotherapy.

[6]  T. Walsh,et al.  Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice , 1989, Infection and immunity.

[7]  J. Sculier,et al.  Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. , 1988, European journal of cancer & clinical oncology.

[8]  L. Frankel,et al.  Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Levron,et al.  The pharmacokinetics of itraconazole in animals and man: an overview , 1987 .

[10]  P. Bierling,et al.  Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients , 1986, Cancer.

[11]  J. Perfect,et al.  Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits , 1986, Antimicrobial Agents and Chemotherapy.

[12]  A. Zuger,et al.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. , 1986, Annals of internal medicine.

[13]  J. Reuben,et al.  Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.

[14]  J. Graybill,et al.  R 51211 (itraconazole) therapy of murine cryptococcosis. , 1984, Sabouraudia.

[15]  F. Szoka,et al.  Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice , 1984, Antimicrobial Agents and Chemotherapy.

[16]  B. Strom,et al.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.

[17]  G. Lopez-Berestein,et al.  Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. , 1984, Cancer drug delivery.

[18]  E. Hersh,et al.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. , 1983, The Journal of infectious diseases.

[19]  J. Kersey,et al.  A Prospective Study of Infectious Diseases Following Bone Marrow Transplantation: Emergence of Aspergillus and Cytomegalovirus as the Major Causes of Mortality , 1983, Infection Control.

[20]  E. Wisse,et al.  UPTAKE OF LIPOSOMES BY RAT AND MOUSE HEPATOCYTES AND KUPFFER CELLS , 1983 .

[21]  W. Lee,et al.  Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.

[22]  J. Graybill,et al.  Amphotericin B in liposomes: a novel therapy for histoplasmosis. , 1982, The American review of respiratory disease.

[23]  L. Young.  Nosocomial infections in the immunocompromised adult. , 1981, The American journal of medicine.